NIH supports investigator-initiated program projects on infectious and immune-mediated diseases requiring at least two related research projects and an administrative core; clinical trials are not allowed.
The National Institutes of Health supports investigator-initiated, multidisciplinary research programs organized around a shared scientific theme, with clinical trials optional.
Supports investigator-initiated resources for high-priority projects or the broader allergy and infectious diseases research community when other NIAID support is unsuitable; clinical trials are not allowed.
Research grant for studying biological, behavioral, and social factors impacting HIV pathogenesis within NIDDK's mission and NIH priorities.
Supports investigator-initiated, milestone-driven clinical trials requiring enhanced oversight for up to 7 years, with mechanistic studies as applicable and one trial per application.
Supporting projects developing innovative technologies for biomedical research, advancing current capabilities for acquiring biomedical knowledge.